Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
927.15
3.50
(0.38%)
< Home
< Back
Natco Pharma Ltd. News
>>
Natco Pharma rises on getting USFDA’s tentative approval for Trabectedin for Injection
>>
Natco Pharma gets USFDA’s tentative approval for Trabectedin for Injection
>>
Natco Pharma - Quaterly Results
>>
Natco Pharma - Quaterly Results
>>
Natco Pharma - Quaterly Results
>>
Natco Pharma rises on getting approval for its partner’s ANDA for Cabazitaxel Intravenous Solution
>>
Natco Pharma gets approval for its partner’s ANDA for Cabazitaxel Intravenous Solution
>>
NATCO Pharma informs about press release
>>
NATCO Pharma informs about transcript of conference call
>>
Natco Pharma surges on launching first generic version of Nexavar Tablets in US market
<<
<
14
15
16
...52
>
>>